ASP Isotopes (ASPI) Financials

$7.65 -0.13 (-1.67%)

Closing price 04:00 PM Eastern

Extended Trading

$7.58 -0.08 (-0.98%)

As of 07:46 PM Eastern

Annual Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-35	-16	-4.95
Consolidated Net Income / (Loss)	-32	-16	-4.95
Net Income / (Loss) Continuing Operations	-32	-16	-4.95
Total Pre-Tax Income	-32	-16	-4.95
Total Operating Income	-26	-16	-5.10
Total Gross Profit	1.60	0.14	0.00
Total Revenue	4.14	0.43	0.00
Operating Revenue	4.14	0.43	0.00
Total Cost of Revenue	2.54	0.29	0.00
Operating Cost of Revenue	2.54	0.29	0.00
Total Operating Expenses	28	16	5.10
Selling, General & Admin Expense	25	15	3.83
Research & Development Expense	3.14	0.76	1.27
Total Other Income / (Expense), net	-5.96	-0.26	0.15
Interest Expense	0.26	0.12	0.00
Interest & Investment Income	1.24	0.01	0.00
Other Income / (Expense), net	-6.94	-0.15	0.15
Income Tax Expense	0.11	-0.01	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.09	-0.01	0.00
Basic Earnings per Share	($0.63)	($0.49)	-
Weighted Average Basic Shares Outstanding	55.67M	33.07M	26.79M
Diluted Earnings per Share	($0.63)	($0.49)	-
Weighted Average Diluted Shares Outstanding	55.67M	33.07M	26.79M
Weighted Average Basic & Diluted Shares Outstanding	72.07M	33.07M	26.79M

This table shows ASP Isotopes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-9.18	-7.27	-12	-6.95	-4.16	-4.22	-4.29	-3.62	-	-1.81
Consolidated Net Income / (Loss)	-9.22	-7.36	-8.88	-6.96	-4.17	-4.22	-4.29	-3.62	-	-3.91
Net Income / (Loss) Continuing Operations	-9.13	-7.36	-8.88	-7.06	-4.17	-4.22	-4.29	-3.62	-	-3.91
Total Pre-Tax Income	-9.07	-7.36	-8.87	-7.01	-4.18	-4.22	-4.29	-3.62	-	-3.91
Total Operating Income	-7.65	-5.43	-7.46	-5.81	-4.02	-3.95	-4.35	-3.72	-	-1.95
Total Gross Profit	0.61	0.29	0.42	0.28	0.14	0.00	0.00	0.00	-	0.00
Total Revenue	1.19	1.09	1.02	0.84	0.43	0.00	0.00	0.00	-	0.00
Operating Revenue	1.19	1.09	1.02	0.84	0.43	0.00	0.00	0.00	-	-
Total Cost of Revenue	0.59	0.79	0.60	0.56	0.29	0.00	0.00	0.00	-	0.00
Operating Cost of Revenue	0.59	0.79	0.60	0.56	0.29	0.00	0.00	0.00	-	-
Total Operating Expenses	8.25	5.73	7.88	6.09	4.16	3.95	4.35	3.72	-	3.91
Selling, General & Admin Expense	6.84	4.69	7.41	5.88	4.10	3.71	4.09	3.52	-	1.21
Research & Development Expense	1.42	1.03	0.47	0.22	0.07	0.24	0.25	0.21	-	0.75
Total Other Income / (Expense), net	-1.42	-1.93	-1.41	-1.20	-0.15	-0.28	0.06	0.11	-	-0.00
Interest Expense	0.09	0.09	0.07	0.01	0.12	0.00	0.00	0.00	-	-
Interest & Investment Income	0.58	0.60	0.04	0.01	0.00	0.00	0.00	0.00	-	0.00
Other Income / (Expense), net	-1.92	-2.44	-1.38	-1.20	-0.04	-0.28	0.06	0.11	-	-0.00
Income Tax Expense	0.06	-0.01	0.01	0.05	-0.01	0.00	0.00	0.00	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.04	-0.08	0.05	-0.02	-0.01	0.00	0.00	0.00	-	-
Weighted Average Basic Shares Outstanding	55.67M	61.53M	66.69M	51.76M	33.07M	31.15M	29.80M	29.14M	26.79M	30.11M
Weighted Average Diluted Shares Outstanding	55.67M	61.53M	66.69M	51.76M	33.07M	31.15M	29.80M	29.14M	26.79M	-
Weighted Average Basic & Diluted Shares Outstanding	72.07M	71.39M	49.14M	44.56M	33.07M	31.15M	29.80M	29.14M	26.79M	-

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	54	5.52	-0.77
Net Cash From Operating Activities	-17	-5.41	-2.94
Net Cash From Continuing Operating Activities	-17	-5.41	-2.94
Net Income / (Loss) Continuing Operations	-32	-16	-4.95
Consolidated Net Income / (Loss)	-32	-16	-4.95
Depreciation Expense	0.47	0.04	0.00
Non-Cash Adjustments To Reconcile Net Income	18	9.58	1.93
Changes in Operating Assets and Liabilities, net	-2.34	1.26	0.07
Net Cash From Investing Activities	-11	-2.45	-4.47
Net Cash From Continuing Investing Activities	-11	-2.45	-4.47
Purchase of Property, Plant & Equipment	-9.68	-2.33	-4.47
Acquisitions	0.00	-0.12	0.00
Other Investing Activities, net	-1.70	0.00	-
Net Cash From Financing Activities	83	13	6.64
Net Cash From Continuing Financing Activities	83	13	6.64
Repayment of Debt	-0.61	-0.70	0.00
Repurchase of Common Equity	-3.65	-0.56	-1.47
Issuance of Debt	26	0.53	0.00
Issuance of Common Equity	53	14	8.12
Other Financing Activities, net	7.27	-0.01	-0.01

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	11	23	6.53	14	5.57	-0.47	-1.71	2.13	0.82	-
Net Cash From Operating Activities	-3.76	-4.84	-5.12	-2.97	-2.06	-0.65	-1.26	-1.44	-0.86	-
Net Cash From Continuing Operating Activities	-3.76	-7.30	-0.60	-5.03	-2.06	0.17	-1.51	-2.01	-1.80	-
Net Income / (Loss) Continuing Operations	-9.22	-7.36	-8.88	-6.96	-4.17	-4.22	-4.29	-3.62	-1.30	-
Consolidated Net Income / (Loss)	-9.22	-7.36	-8.88	-6.96	-4.17	-4.22	-4.29	-3.62	-1.30	-
Depreciation Expense	0.05	0.18	0.15	0.10	0.04	0.00	0.00	0.00	-	-
Non-Cash Adjustments To Reconcile Net Income	4.65	5.91	5.88	1.15	2.16	2.90	2.37	2.14	0.99	-
Changes in Operating Assets and Liabilities, net	0.76	-6.04	2.36	0.58	-0.09	1.52	0.38	-0.55	-1.43	-
Net Cash From Investing Activities	-3.02	-4.48	-2.62	-1.25	-1.26	-0.68	-0.15	-0.36	-0.90	-
Net Cash From Continuing Investing Activities	-3.02	-4.48	-2.62	-1.25	-1.26	-0.68	-0.15	-0.36	-0.90	-
Purchase of Property, Plant & Equipment	-1.32	-4.48	-2.62	-1.25	-1.14	-0.68	-0.15	-0.36	-0.90	-
Net Cash From Financing Activities	18	32	12	20	8.89	-	-	4.49	3.79	-
Net Cash From Continuing Financing Activities	18	32	12	20	8.89	-	-	4.49	3.79	-
Repayment of Debt	-0.17	-	-0.18	-0.26	-0.70	-	-	0.00	0.01	-
Repurchase of Common Equity	-1.45	-2.19	-	-	-0.06	-	-	-	-1.21	-
Issuance of Debt	0.50	-	5.39	21	0.53	-	-	0.00	-	-
Issuance of Common Equity	19	29	5.54	0.00	9.13	-	-	5.00	5.00	-
Other Financing Activities, net	0.23	5.57	1.48	-0.01	-0.01	-	0.51	-0.51	-	-

This table presents ASP Isotopes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	94	28	12
Total Current Assets	66	11	3.30
Cash & Equivalents	62	7.91	2.39
Accounts Receivable	0.71	0.22	0.00
Inventories, net	0.07	0.00	-
Prepaid Expenses	3.05	1.66	0.91
Other Current Assets	0.03	0.72	0.00
Plant, Property, & Equipment, net	22	11	8.20
Total Noncurrent Assets	6.25	6.32	0.99
Goodwill	3.17	3.27	0.00
Noncurrent Deferred & Refundable Income Taxes	0.03	0.00	-
Other Noncurrent Operating Assets	3.05	3.05	0.99
Total Liabilities & Shareholders' Equity	94	28	12
Total Liabilities	43	8.71	2.68
Total Current Liabilities	7.06	5.67	1.94
Short-Term Debt	0.94	0.47	0.03
Accounts Payable	1.02	1.11	1.35
Accrued Expenses	2.28	1.31	0.36
Current Deferred Revenue	0.88	0.88	0.00
Other Current Liabilities	1.94	1.90	0.19
Total Noncurrent Liabilities	36	3.04	0.74
Long-Term Debt	33	0.00	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.11	0.00
Other Noncurrent Operating Liabilities	2.69	2.93	0.74
Commitments & Contingencies	0.00	0.00	-
Total Equity & Noncontrolling Interests	51	19	9.82
Total Preferred & Common Equity	48	16	9.82
Preferred Stock	0.00	0.00	0.00
Total Common Equity	48	16	9.82
Common Stock	106	41	17
Retained Earnings	-56	-24	-7.55
Accumulated Other Comprehensive Income / (Loss)	-2.16	-0.92	0.26
Noncontrolling Interest	3.27	2.53	0.00

This table presents ASP Isotopes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023
Total Assets	84	55	45	12
Total Current Assets	56	32	26	2.73
Cash & Equivalents	52	28	24	2.29
Accounts Receivable	0.56	0.52	0.35	-
Inventories, net	0.08	-	-	-
Prepaid Expenses	3.87	3.25	1.93	0.44
Other Current Assets	0.00	0.05	0.00	-
Plant, Property, & Equipment, net	23	18	14	8.35
Total Noncurrent Assets	5.05	4.91	4.85	0.80
Goodwill	3.46	3.29	3.17	-
Other Noncurrent Operating Assets	1.59	1.63	1.68	0.80
Total Liabilities & Shareholders' Equity	84	55	45	12
Total Liabilities	42	40	32	3.23
Total Current Liabilities	7.43	8.01	7.33	2.60
Short-Term Debt	0.03	0.03	0.21	0.03
Accounts Payable	1.80	2.43	2.22	0.40
Accrued Expenses	1.76	2.46	1.77	1.09
Current Deferred Revenue	0.88	0.88	0.88	0.88
Other Current Liabilities	2.95	2.21	2.25	0.19
Total Noncurrent Liabilities	35	32	25	0.63
Long-Term Debt	32	29	22	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.08	0.07	0.06	-
Other Noncurrent Operating Liabilities	2.83	3.23	2.95	0.63
Commitments & Contingencies	0.00	-	-	-
Total Equity & Noncontrolling Interests	42	14	13	8.64
Total Preferred & Common Equity	39	11	11	8.64
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	39	11	11	8.64
Common Stock	85	51	43	30
Retained Earnings	-47	-40	-31	-20
Accumulated Other Comprehensive Income / (Loss)	0.60	-0.70	-1.46	-1.29
Noncontrolling Interest	3.32	3.35	2.51	-

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	857.04%	0.00%	0.00%
EBITDA Growth	-103.18%	-226.43%	0.00%
EBIT Growth	-105.62%	-227.18%	0.00%
NOPAT Growth	-64.28%	-214.61%	0.00%
Net Income Growth	-98.98%	-229.50%	0.00%
EPS Growth	-28.57%	0.00%	0.00%
Operating Cash Flow Growth	-208.47%	-84.10%	0.00%
Free Cash Flow Firm Growth	-102.53%	0.00%	0.00%
Invested Capital Growth	107.57%	52.67%	0.00%
Revenue Q/Q Growth	22.49%	0.00%	0.00%
EBITDA Q/Q Growth	-20.10%	-1,667,112.69%	0.00%
EBIT Q/Q Growth	-19.80%	0.00%	0.00%
NOPAT Q/Q Growth	-15.95%	0.00%	0.00%
Net Income Q/Q Growth	-18.45%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-11.36%	-28.34%	0.00%
Free Cash Flow Firm Q/Q Growth	3.38%	0.00%	0.00%
Invested Capital Q/Q Growth	6.28%	78.39%	0.00%
Profitability Metrics	-	-	-
Gross Margin	38.60%	32.09%	0.00%
EBITDA Margin	-791.94%	-3,730.34%	0.00%
Operating Margin	-635.91%	-3,704.63%	0.00%
EBIT Margin	-803.31%	-3,738.99%	0.00%
Profit (Net Income) Margin	-782.36%	-3,762.85%	0.00%
Tax Burden Percent	100.34%	99.96%	100.00%
Interest Burden Percent	97.06%	100.68%	99.93%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-105.29%	-119.11%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-25.33%	-15.68%	0.00%
Return on Net Nonoperating Assets (RNNOA)	12.65%	5.36%	0.00%
Return on Equity (ROE)	-92.64%	-113.75%	-100.74%
Cash Return on Invested Capital (CROIC)	-175.24%	-160.81%	0.00%
Operating Return on Assets (OROA)	-54.62%	-80.88%	0.00%
Return on Assets (ROA)	-53.20%	-81.39%	0.00%
Return on Common Equity (ROCE)	-84.96%	-103.69%	-100.74%
Return on Equity Simple (ROE_SIMPLE)	-67.69%	-99.99%	-50.37%
Net Operating Profit after Tax (NOPAT)	-18	-11	-3.57
NOPAT Margin	-445.14%	-2,593.24%	0.00%
Net Nonoperating Expense Percent (NNEP)	-79.96%	-103.43%	-58.41%
Return On Investment Capital (ROIC_SIMPLE)	-21.57%	-58.18%	-
Cost of Revenue to Revenue	61.40%	67.91%	0.00%
SG&A Expenses to Revenue	598.77%	3,560.15%	0.00%
R&D to Revenue	75.74%	176.57%	0.00%
Operating Expenses to Revenue	674.51%	3,736.72%	0.00%
Earnings before Interest and Taxes (EBIT)	-33	-16	-4.95
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-33	-16	-4.95
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	6.75	5.36	0.00
Price to Tangible Book Value (P/TBV)	7.23	6.70	0.00
Price to Revenue (P/Rev)	78.04	201.61	0.00
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12.65	7.23	0.00
Enterprise Value to Revenue (EV/Rev)	72.18	190.29	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.67	0.03	0.00
Long-Term Debt to Equity	0.65	0.00	0.00
Financial Leverage	-0.50	-0.34	-0.24
Leverage Ratio	1.74	1.40	1.27
Compound Leverage Factor	1.69	1.41	1.27
Debt to Total Capital	40.18%	2.44%	0.34%
Short-Term Debt to Total Capital	1.10%	2.44%	0.34%
Long-Term Debt to Total Capital	39.09%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.82%	13.13%	0.00%
Common Equity to Total Capital	56.00%	84.43%	99.66%
Debt to EBITDA	-1.05	-0.03	-0.01
Net Debt to EBITDA	0.84	0.46	0.48
Long-Term Debt to EBITDA	-1.02	0.00	0.00
Debt to NOPAT	-1.86	-0.04	-0.01
Net Debt to NOPAT	1.49	0.66	0.66
Long-Term Debt to NOPAT	-1.81	0.00	0.00
Altman Z-Score	3.29	3.09	0.00
Noncontrolling Interest Sharing Ratio	8.29%	8.85%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	9.31	1.85	1.71
Quick Ratio	8.87	1.43	1.23
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-31	-15	0.00
Operating Cash Flow to CapEx	-172.56%	-232.16%	-65.72%
Free Cash Flow to Firm to Interest Expense	-118.61	-127.88	0.00
Operating Cash Flow to Interest Expense	-64.49	-45.66	0.00
Operating Cash Flow Less CapEx to Interest Expense	-101.87	-65.32	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.07	0.02	0.00
Accounts Receivable Turnover	8.98	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.25	0.05	0.00
Accounts Payable Turnover	2.39	0.24	0.00
Days Sales Outstanding (DSO)	40.67	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	152.99	1,530.92	0.00
Cash Conversion Cycle (CCC)	-112.33	-1,530.92	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	24	11	7.46
Invested Capital Turnover	0.24	0.05	0.00
Increase / (Decrease) in Invested Capital	12	3.93	0.00
Enterprise Value (EV)	299	82	0.00
Market Capitalization	323	87	0.00
Book Value per Share	$0.67	$0.33	$0.37
Tangible Book Value per Share	$0.63	$0.27	$0.37
Total Capital	86	19	9.85
Total Debt	34	0.47	0.03
Total Long-Term Debt	33	0.00	0.00
Net Debt	-28	-7.44	-2.36
Capital Expenditures (CapEx)	9.68	2.33	4.47
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.27	-2.60	-0.99
Debt-free Net Working Capital (DFNWC)	60	5.31	1.40
Net Working Capital (NWC)	59	4.84	1.37
Net Nonoperating Expense (NNE)	14	5.06	1.38
Net Nonoperating Obligations (NNO)	-28	-7.44	-2.36
Total Depreciation and Amortization (D&A)	0.47	0.04	0.00
Debt-free, Cash-free Net Working Capital to Revenue	-54.67%	-600.77%	0.00%
Debt-free Net Working Capital to Revenue	1,438.74%	1,225.49%	0.00%
Net Working Capital to Revenue	1,416.08%	1,116.86%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.63)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	55.67M	33.07M	0.00
Adjusted Diluted Earnings per Share	($0.63)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	55.67M	33.07M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	72.07M	33.07M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-18	-11	-3.57
Normalized NOPAT Margin	-445.14%	-2,593.24%	0.00%
Pre Tax Income Margin	-779.67%	-3,764.27%	0.00%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-128.60	-136.58	0.00
NOPAT to Interest Expense	-71.26	-94.73	0.00
EBIT Less CapEx to Interest Expense	-165.98	-156.24	0.00
NOPAT Less CapEx to Interest Expense	-108.64	-114.39	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-11.25%	-3.46%	-29.63%

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	175.71%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	-136.43%	-82.22%	-103.56%	-89.22%	0.00%	-115.98%	0.00%	0.00%	0.00%	0.00%
EBIT Growth	-135.43%	-86.35%	-106.23%	-93.91%	0.00%	-116.02%	0.00%	0.00%	0.00%	0.00%
NOPAT Growth	-90.10%	-37.68%	-71.53%	-56.11%	0.00%	-101.99%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	-121.12%	-74.20%	-107.20%	-92.66%	0.00%	-7.92%	0.00%	0.00%	0.00%	0.00%
EPS Growth	0.00%	14.29%	0.00%	0.00%	0.00%	-133.33%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	-82.76%	-640.92%	-307.72%	-105.57%	-138.65%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	-161.00%	-114.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	107.57%	248.42%	0.00%	0.00%	52.67%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	9.76%	6.40%	21.65%	94.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-23.62%	11.46%	-27.71%	-69.15%	4.73%	1.09%	-18.71%	0.00%	100.00%	0.00%
EBIT Q/Q Growth	-21.44%	10.94%	-26.12%	-72.60%	3.88%	1.43%	-18.59%	0.00%	100.00%	0.00%
NOPAT Q/Q Growth	-40.75%	27.14%	-28.25%	-44.53%	-1.94%	9.22%	-16.72%	0.00%	100.00%	0.00%
Net Income Q/Q Growth	-25.36%	17.18%	-27.52%	-13,426.27%	1.24%	1.49%	-18.57%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	22.32%	5.55%	-72.52%	-44.39%	-214.91%	48.03%	13.01%	-67.62%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	10.47%	3.76%	-32.45%	-128.71%	26.26%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	6.28%	46.23%	33.96%	-0.29%	78.39%	0.00%	0.00%	-100.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.74%	27.03%	41.18%	33.18%	32.09%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	-797.18%	-707.83%	-850.59%	-810.25%	-929.61%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	-640.58%	-499.55%	-729.48%	-691.95%	-929.07%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	-801.01%	-724.01%	-864.93%	-834.28%	-938.03%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	-772.36%	-676.24%	-868.77%	-828.80%	-963.04%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	101.69%	99.89%	100.16%	99.32%	99.85%	100.00%	100.00%	100.00%	0.00%	100.07%
Interest Burden Percent	94.82%	93.51%	100.29%	100.02%	102.82%	99.92%	99.97%	99.99%	0.00%	199.85%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-106.06%	-82.62%	-154.06%	-108.59%	-29.87%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-83.93%	-50.35%	-1,009.54%	238.73%	-2.22%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	41.92%	21.88%	-60.17%	-30.54%	0.76%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-64.15%	-60.74%	-214.23%	-139.13%	-29.11%	0.00%	0.00%	0.00%	-100.74%	0.00%
Cash Return on Invested Capital (CROIC)	-175.24%	-221.91%	-395.42%	-423.45%	-160.81%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-54.47%	-51.03%	-72.52%	-46.81%	-20.29%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	-52.52%	-47.67%	-72.84%	-46.51%	-20.83%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-58.83%	-56.76%	-164.26%	-112.33%	-26.54%	0.00%	0.00%	0.00%	-100.74%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-70.74%	-220.12%	-186.77%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.35	-3.80	-5.22	-4.07	-2.82	-2.76	-3.04	-2.61	0.00	-1.37
NOPAT Margin	-448.41%	-349.69%	-510.64%	-484.36%	-650.35%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-22.13%	-32.27%	855.48%	-347.31%	-27.65%	-129.60%	0.00%	0.00%	0.00%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-6.26%	-	-	-	-14.59%	-	-	-	-	-
Cost of Revenue to Revenue	49.26%	72.97%	58.82%	66.82%	67.91%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	572.71%	431.48%	724.37%	699.53%	946.11%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	118.61%	95.10%	46.30%	25.60%	15.05%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	691.32%	526.58%	770.66%	725.13%	961.16%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-9.56	-7.87	-8.84	-7.01	-4.06	-4.23	-4.29	-3.62	0.00	-1.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-9.52	-7.70	-8.70	-6.81	-4.03	-4.23	-4.27	-3.60	0.00	-1.96
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.75	4.79	14.38	19.15	5.36	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	7.23	5.26	20.51	27.40	6.70	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	78.04	54.79	69.00	158.19	201.61	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12.65	7.59	10.69	17.81	7.23	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	72.18	49.93	70.83	158.85	190.29	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.67	0.76	2.03	1.71	0.03	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.65	0.76	2.03	1.69	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.50	-0.43	0.06	-0.13	-0.34	-0.26	0.00	0.00	-0.24	0.00
Leverage Ratio	1.74	1.90	3.81	3.48	1.40	1.37	0.00	0.00	1.27	0.00
Compound Leverage Factor	1.65	1.77	3.82	3.48	1.44	1.37	0.00	0.00	0.00	0.00
Debt to Total Capital	40.18%	43.09%	66.97%	63.05%	2.44%	0.39%	0.00%	0.00%	0.34%	0.00%
Short-Term Debt to Total Capital	1.10%	0.05%	0.07%	0.59%	2.44%	0.39%	0.00%	0.00%	0.34%	0.00%
Long-Term Debt to Total Capital	39.09%	43.05%	66.90%	62.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.82%	4.49%	7.71%	7.12%	13.13%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.00%	52.42%	25.33%	29.84%	84.43%	99.61%	0.00%	0.00%	99.66%	0.00%
Debt to EBITDA	-1.05	-1.16	-1.22	-1.14	-0.03	34.94	0.00	0.00	-0.01	0.00
Net Debt to EBITDA	0.84	0.72	-0.04	0.09	0.46	-2,325.03	0.00	0.00	0.48	0.00
Long-Term Debt to EBITDA	-1.02	-1.16	-1.22	-1.13	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-1.86	-2.00	-1.96	-1.75	-0.04	0.00	0.00	0.00	-0.01	0.00
Net Debt to NOPAT	1.49	1.24	-0.06	0.13	0.66	0.00	0.00	0.00	0.66	0.00
Long-Term Debt to NOPAT	-1.81	-2.00	-1.96	-1.73	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.12	2.28	1.37	2.80	4.54	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	8.29%	6.55%	23.33%	19.26%	8.85%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	9.31	7.55	4.00	3.57	1.85	1.05	0.00	0.00	1.71	0.00
Quick Ratio	8.87	7.02	3.59	3.31	1.43	0.88	0.00	0.00	1.23	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-18	-20	-20	-15	-6.75	-9.15	0.00	0.00	0.00	0.00
Operating Cash Flow to CapEx	-284.25%	-107.93%	-195.45%	-238.43%	-180.27%	-95.85%	-857.67%	-399.10%	-95.51%	0.00%
Free Cash Flow to Firm to Interest Expense	-207.08	-216.23	-295.87	-1,119.13	-56.91	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-44.21	-53.21	-74.19	-215.44	-17.35	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-59.77	-102.51	-112.15	-305.79	-26.98	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.07	0.07	0.08	0.06	0.02	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	8.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.25	0.22	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	2.39	2.05	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	40.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	152.99	178.36	0.00	0.00	1,530.92	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	-112.33	-178.36	0.00	0.00	-1,530.92	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	24	22	15	11	11	6.39	0.00	0.00	7.46	0.00
Invested Capital Turnover	0.24	0.24	0.30	0.22	0.05	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	12	16	15	11	3.93	6.39	0.00	0.00	0.00	0.00
Enterprise Value (EV)	299	169	163	202	82	0.00	0.00	0.00	0.00	5.00
Market Capitalization	323	185	158	201	87	0.00	0.00	0.00	0.00	5.00
Book Value per Share	$0.67	$0.58	$0.21	$0.22	$0.33	$0.28	$0.00	$0.00	$0.37	$0.00
Tangible Book Value per Share	$0.63	$0.53	$0.15	$0.15	$0.27	$0.28	$0.00	$0.00	$0.37	$0.00
Total Capital	86	74	43	35	19	8.67	0.00	0.00	9.85	0.00
Total Debt	34	32	29	22	0.47	0.03	0.00	0.00	0.03	0.00
Total Long-Term Debt	33	32	29	22	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-28	-20	0.86	-1.67	-7.44	-2.25	0.00	0.00	-2.36	0.00
Capital Expenditures (CapEx)	1.32	4.48	2.62	1.25	1.14	0.68	0.15	0.36	0.90	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.27	-2.87	-4.17	-4.84	-2.60	-2.13	0.00	0.00	-0.99	0.00
Debt-free Net Working Capital (DFNWC)	60	49	24	19	5.31	0.16	0.00	0.00	1.40	0.00
Net Working Capital (NWC)	59	49	24	19	4.84	0.13	0.00	0.00	1.37	0.00
Net Nonoperating Expense (NNE)	3.87	3.55	3.66	2.89	1.35	1.46	1.24	1.01	0.00	2.54
Net Nonoperating Obligations (NNO)	-28	-20	0.86	-1.67	-7.44	-2.25	0.00	0.00	-2.36	0.00
Total Depreciation and Amortization (D&A)	0.05	0.18	0.15	0.20	0.04	0.00	0.02	0.02	0.00	0.00
Debt-free, Cash-free Net Working Capital to Revenue	-54.67%	-84.97%	-181.67%	-380.09%	-600.77%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	1,438.74%	1,439.29%	1,049.44%	1,496.08%	1,225.49%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	1,416.08%	1,438.31%	1,048.06%	1,479.86%	1,116.86%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.12)	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	55.67M	61.53M	66.69M	51.76M	33.07M	48.77M	0.00	0.00	26.79M	0.00
Adjusted Diluted Earnings per Share	$0.00	($0.12)	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	55.67M	61.53M	66.69M	51.76M	33.07M	48.77M	0.00	0.00	26.79M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	72.07M	71.39M	49.14M	44.56M	33.07M	31.15M	0.00	0.00	26.79M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-5.35	-3.80	-5.22	-4.07	-2.82	-2.76	-3.04	-2.61	0.00	-1.37
Normalized NOPAT Margin	-448.41%	-349.69%	-510.64%	-484.36%	-650.35%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	-759.49%	-677.01%	-867.42%	-834.47%	-964.46%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-112.46	-86.57	-128.00	-508.48	-34.26	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-62.96	-41.81	-75.57	-295.21	-23.76	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-128.02	-135.87	-165.96	-598.83	-43.89	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-78.51	-91.11	-113.53	-385.57	-33.38	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-11.25%	-8.22%	-0.24%	0.00%	-3.46%	0.00%	0.00%	0.00%	-29.63%	0.00%

Frequently Asked Questions About ASP Isotopes' Financials

When does ASP Isotopes's fiscal year end?

According to the most recent income statement we have on file, ASP Isotopes' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ASP Isotopes' net income changed over the last 2 years?

ASP Isotopes' net income appears to be on an upward trend, with a most recent value of -$32.42 million in 2024, rising from -$4.95 million in 2022. The previous period was -$16.29 million in 2023. Find out what analysts predict for ASP Isotopes in the coming months.

What is ASP Isotopes's operating income?

ASP Isotopes's total operating income in 2024 was -$26.35 million, based on the following breakdown:

Total Gross Profit: $1.60 million
Total Operating Expenses: $27.95 million

How has ASP Isotopes revenue changed over the last 2 years?

Over the last 2 years, ASP Isotopes' total revenue changed from $0.00 in 2022 to $4.14 million in 2024, a change of 414,422,600.0%.

How much debt does ASP Isotopes have?

ASP Isotopes' total liabilities were at $43.18 million at the end of 2024, a 395.7% increase from 2023, and a 1,512.0% increase since 2022.

How much cash does ASP Isotopes have?

In the past 2 years, ASP Isotopes' cash and equivalents has ranged from $2.39 million in 2022 to $61.89 million in 2024, and is currently $61.89 million as of their latest financial filing in 2024.

How has ASP Isotopes' book value per share changed over the last 2 years?

Over the last 2 years, ASP Isotopes' book value per share changed from 0.37 in 2022 to 0.67 in 2024, a change of 83.1%.

Related Companies

This page (NASDAQ:ASPI) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Financials

Frequently Asked Questions About ASP Isotopes' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Financials

Annual Income Statements for ASP Isotopes

Quarterly Income Statements for ASP Isotopes

Annual Cash Flow Statements for ASP Isotopes

Quarterly Cash Flow Statements for ASP Isotopes

Annual Balance Sheets for ASP Isotopes

Quarterly Balance Sheets for ASP Isotopes

Annual Metrics And Ratios for ASP Isotopes

Quarterly Metrics And Ratios for ASP Isotopes

Frequently Asked Questions About ASP Isotopes' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools